# FDA Inspection 806330 - Octapharma Plasma, Inc. - October 25, 2012

Source: https://www.globalkeysolutions.net/records/fda_inspections/octapharma-plasma-inc/4ab56a7e-194b-4b75-a03f-b5211d3d8cb4
Source feed: FDA_Inspections

> FDA Inspection 806330 for Octapharma Plasma, Inc. on October 25, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 806330
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2012-10-25
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1089657 - 2019-04-24](https://www.globalkeysolutions.net/records/fda_inspections/octapharma-plasma-inc/d47fd450-a1a8-4e3b-b651-8abab62724d6)
- [FDA Inspection 976436 - 2016-06-30](https://www.globalkeysolutions.net/records/fda_inspections/octapharma-plasma-inc/517bc88b-535b-4747-bf9f-d766da951934)
- [FDA Inspection 614657 - 2009-09-24](https://www.globalkeysolutions.net/records/fda_inspections/octapharma-plasma-inc/5e2e6897-4bfa-46e5-bbde-14ef9d6697cd)

Company: https://www.globalkeysolutions.net/companies/octapharma-plasma-inc/01c56ab1-5b65-4777-ae72-321592e2ba85

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d